The application of monoclonal antibodies in the cytologic evaluation of tumors.
The focus of this review has been the application of MAbs as adjuncts in the interpretation of cytology specimens. It is evident that most if not all of the MAbs studied thus far are neither completely tumor-specific nor -sensitive; however, when used to address a directed clinical question, they may be "operationally specific." More important, there continues to be no current substitute for the understanding and practice of sound diagnostic cytopathologic principles. Ultimately, the application of MAbs resides in the importance of tumor-associated antigen expression and phenotyping of tumors with therapeutic and prognostic implications.
Department of Pathology, Duke University Medical Center, Durham, North Carolina.
C
C
Szpak
R E
RE
McLendon
J F
JF
Simpson
A
A
Thor
W W
WW
Johnston
D000911:Antibodies, Monoclonal; D014408:Biomarkers, Tumor / Q000032:analysis; D001707:Biopsy, Needle; D003581:Cytodiagnosis; D003937:Diagnosis, Differential; D004848:Epithelium / Q000473:pathology; D005122:Exudates and Transudates / Q000166:cytology; D006801:Humans; D009369:Neoplasms / Q000032:analysis / Q000175:diagnosis* / Q000473:pathology; D010533:Peritoneal Lavage
D000911:Antibodies, Monoclonal; D014408:Biomarkers, Tumor